# COQ9

## Overview
The COQ9 gene encodes a mitochondrial lipid-binding protein that is integral to the biosynthesis of coenzyme Q10 (CoQ10), a vital component of the electron transport chain and a potent antioxidant. The COQ9 protein is not a transcription factor but shares structural homology with the TFR family and plays a critical role in stabilizing COQ7, another protein involved in CoQ10 biosynthesis. This stabilization is essential for the hydroxylation of 6-demethoxy CoQ10, a key step in the CoQ biosynthetic pathway (Danhauser2015Fatal). COQ9 is part of a multiprotein complex that enhances the efficiency of CoQ10 production, ensuring proper mitochondrial function and energy metabolism, particularly in tissues with high energy demands (Luna‐Sánchez2015The). Mutations in COQ9 can lead to primary CoQ10 deficiency, resulting in a range of clinical manifestations, including severe infantile multisystemic disorders and encephalomyopathy (Olgac2019A; Smith2018A).

## Function
The COQ9 gene encodes a mitochondrial protein that plays a crucial role in the biosynthesis of coenzyme Q10 (CoQ10), an essential component of the electron transport chain in mitochondria. COQ9 is involved in stabilizing COQ7, another protein in the CoQ10 biosynthesis pathway, and may form a complex with COQ7 to facilitate the hydroxylation of 6-demethoxy CoQ10, a critical step in CoQ biosynthesis (Danhauser2015Fatal). The COQ9 protein is a lipid-binding protein with structural homology to the TFR family, although it is unlikely to function as a transcription factor (Danhauser2015Fatal).

In healthy human cells, COQ9 is essential for maintaining adequate CoQ10 levels, which are vital for mitochondrial energy metabolism. CoQ10 functions as an electron carrier, transferring electrons from complexes I and II to complex III in the mitochondrial respiratory chain, and also acts as a potent antioxidant in its reduced form (Danhauser2015Fatal). The COQ9 protein is part of a multiprotein complex that enhances the catalytic efficiency of CoQ biosynthesis, ensuring proper mitochondrial function and energy production (Luna‐Sánchez2015The). COQ9's activity is crucial for cellular respiration and energy metabolism, particularly in tissues with high energy demands.

## Clinical Significance
Mutations in the COQ9 gene are associated with a range of clinical conditions due to its role in coenzyme Q10 (CoQ10) biosynthesis. Primary CoQ10 deficiency, resulting from COQ9 mutations, is a mitochondrial disorder with multisystem involvement, often inherited in an autosomal recessive manner. This deficiency can manifest as encephalomyopathy, severe infantile multisystemic disorder, cerebellar ataxia, isolated myopathy, and nephrotic syndrome (Olgac2019A; Smith2018A). 

In neonates, COQ9 mutations can lead to lethal conditions characterized by oligohydramnios, intrauterine growth restriction, cardiomyopathy, anemia, and renal anomalies. These mutations result in undetectable COQ9 protein levels and drastically reduced CoQ10 levels, causing severe metabolic dysfunction (Smith2018A). 

A specific case involved a 9-month-old girl with growth retardation, microcephaly, and seizures due to a novel frameshift mutation in COQ9. Despite CoQ10 supplementation, significant neurological improvement was not observed, highlighting the challenges in treatment (Olgac2019A). 

Mouse models with COQ9 mutations exhibit encephalomyopathy, characterized by energy depletion in the brain, neuronal death, and oxidative stress, providing insights into the pathomechanisms of COQ deficiency (GarciaCorzo2012Dysfunctional).

## Interactions
COQ9 is involved in the biosynthesis of coenzyme Q10 and participates in several interactions with other proteins within the CoQ-synthome complex. It plays a crucial role in stabilizing the CoQ-synthome, particularly by interacting with COQ7. This interaction is essential for the hydroxylation reaction that COQ7 catalyzes, which is a critical step in CoQ10 production (Herebian2017Detection). COQ9 has been shown to stabilize COQ7, and this interaction is necessary for the proper function of the CoQ-synthome (Yen2020Characterization).

In yeast models, human COQ9 has been demonstrated to interact with yeast Coq polypeptides, such as Coq6, as evidenced by co-precipitation experiments. This suggests a functional conservation between human and yeast COQ9, although the interaction may not be identical to that of yeast Coq9 (He2017Human). The expression of human COQ9 in yeast increases the steady-state levels of yeast Coq4, Coq6, Coq7, and Coq9 polypeptides, indicating that COQ9 may stabilize these proteins within the complex (He2017Human).

COQ9 is also involved in multiprotein complexes in human mitochondria, where it interacts with other COQ proteins, such as COQ5, to maintain CoQ10 levels and stability (Yen2020Characterization). These interactions highlight COQ9's role in the structural and functional integrity of the CoQ biosynthetic pathway.


## References


[1. (Herebian2017Detection) Diran Herebian, Annette Seibt, Sander H.J. Smits, Gisela Bünning, Christoph Freyer, Holger Prokisch, Daniela Karall, Anna Wredenberg, Anna Wedell, Luis C. López, Ertan Mayatepek, and Felix Distelmaier. Detection of 6-demethoxyubiquinone in coq10 deficiency disorders: insights into enzyme interactions and identification of potential therapeutics. Molecular Genetics and Metabolism, 121(3):216–223, July 2017. URL: http://dx.doi.org/10.1016/j.ymgme.2017.05.012, doi:10.1016/j.ymgme.2017.05.012. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ymgme.2017.05.012)

[2. (Smith2018A) Amanda C. Smith, Yoko Ito, Afsana Ahmed, Jeremy A. Schwartzentruber, Chandree L. Beaulieu, Erika Aberg, Jacek Majewski, Dennis E. Bulman, Karina Horsting‐Wethly, Diana Vermunt‐de Koning, Richard J. Rodenburg, Kym M. Boycott, and Lynette S. Penney. A family segregating lethal neonatal coenzyme q10 deficiency caused by mutations in coq9. Journal of Inherited Metabolic Disease, 41(4):719–729, March 2018. URL: http://dx.doi.org/10.1007/s10545-017-0122-7, doi:10.1007/s10545-017-0122-7. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10545-017-0122-7)

[3. (Yen2020Characterization) Hsiu-Chuan Yen, Wen-Yu Yeh, Szu-Hsien Lee, Yu-Hsiu Feng, and Si-Ling Yang. Characterization of human mitochondrial pdss and coq proteins and their roles in maintaining coenzyme q10 levels and each other’s stability. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1861(7):148192, July 2020. URL: http://dx.doi.org/10.1016/j.bbabio.2020.148192, doi:10.1016/j.bbabio.2020.148192. This article has 17 citations.](https://doi.org/10.1016/j.bbabio.2020.148192)

[4. (Danhauser2015Fatal) Katharina Danhauser, Diran Herebian, Tobias B Haack, Richard J Rodenburg, Tim M Strom, Thomas Meitinger, Dirk Klee, Ertan Mayatepek, Holger Prokisch, and Felix Distelmaier. Fatal neonatal encephalopathy and lactic acidosis caused by a homozygous loss-of-function variant in coq9. European Journal of Human Genetics, 24(3):450–454, June 2015. URL: http://dx.doi.org/10.1038/ejhg.2015.133, doi:10.1038/ejhg.2015.133. This article has 43 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2015.133)

[5. (He2017Human) Cuiwen H. He, Dylan S. Black, Christopher M. Allan, Brigitte Meunier, Shamima Rahman, and Catherine F. Clarke. Human coq9 rescues a coq9 yeast mutant by enhancing coenzyme q biosynthesis from 4-hydroxybenzoic acid and stabilizing the coq-synthome. Frontiers in Physiology, July 2017. URL: http://dx.doi.org/10.3389/fphys.2017.00463, doi:10.3389/fphys.2017.00463. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphys.2017.00463)

[6. (Olgac2019A) Asburce Olgac, Ülkühan Öztoprak, Çiğdem Seher Kasapkara, Mustafa Kılıç, Deniz Yüksel, Emine Betül Derinkuyu, Yasemin Taşçı Yıldız, Serdar Ceylaner, and Fatih Süheyl Ezgu. A rare case of primary coenzyme q10 deficiency due to coq9 mutation. Journal of Pediatric Endocrinology and Metabolism, 33(1):165–170, December 2019. URL: http://dx.doi.org/10.1515/jpem-2019-0245, doi:10.1515/jpem-2019-0245. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/jpem-2019-0245)

[7. (Luna‐Sánchez2015The) Marta Luna‐Sánchez, Elena Díaz‐Casado, Emanuele Barca, Miguel Ángel Tejada, Ángeles Montilla‐García, Enrique Javier Cobos, Germaine Escames, Dario Acuña‐Castroviejo, Catarina M Quinzii, and Luis Carlos López. The clinical heterogeneity of coenzyme q10 deficiency results from genotypic differences in the coq9 gene. EMBO Molecular Medicine, 7(5):670–687, March 2015. URL: http://dx.doi.org/10.15252/emmm.201404632, doi:10.15252/emmm.201404632. This article has 71 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.15252/emmm.201404632)

[8. (GarciaCorzo2012Dysfunctional) L. Garcia-Corzo, M. Luna-Sanchez, C. Doerrier, J. A. Garcia, A. Guaras, R. Acin-Perez, J. Bullejos-Peregrin, A. Lopez, G. Escames, J. A. Enriquez, D. Acuna-Castroviejo, and L. C. Lopez. Dysfunctional coq9 protein causes predominant encephalomyopathy associated with coq deficiency. Human Molecular Genetics, 22(6):1233–1248, December 2012. URL: http://dx.doi.org/10.1093/hmg/dds530, doi:10.1093/hmg/dds530. This article has 89 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/dds530)